Literature DB >> 2731987

Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice.

P J Murray1, T W Spithill, E Handman.   

Abstract

The total integral membrane proteins of promastigotes of Leishmania major were extracted by using the Triton X-114 phase separation technique and were characterized by immunoprecipitation, Western blotting (immunoblotting), and lectin chromatography. Of the 40 or more proteins which partitioned into the detergent phase, only about 10 proteins could be surface radioiodinated on live promastigotes, suggesting their surface orientation. The abundance of the gp58-63 antigen varied markedly between two strains of L. major. Sera from patients with visceral leishmaniasis caused by Leishmania donovani chagasi recognized the gp58-63 complex and an additional Mr-42,000 polypeptide shared between L. major and L. donovani chagasi. A subpopulation of six surface proteins, including the abundant gp58-63 antigen and a group of proteins of Mr 81,000 to 105,000, were glycoproteins recognized by antiserum to wheat germ agglutinin- or concanavalin A-binding proteins. The membrane proteins of the LRC-L119 isolate of L. major could successfully vaccinate genetically susceptible mice, thus opening the way for a molecularly defined subunit vaccine composed of glycolipid and membrane protein antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731987      PMCID: PMC313861          DOI: 10.1128/iai.57.7.2203-2209.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

2.  A family of glycoinositol phospholipids from Leishmania major. Isolation, characterization, and antigenicity.

Authors:  M J McConville; A Bacic
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Eukaryotic protein modification and membrane attachment via phosphatidylinositol.

Authors:  G A Cross
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

6.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

7.  Identification and characterization of protein antigens of Leishmania tropica isolates.

Authors:  E Handman; G F Mitchell; J W Goding
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

8.  Immunoblotting analysis of the major integral membrane protein antigens of Schistosoma japonicum.

Authors:  M V Rogers; K M Davern; J A Smythe; G F Mitchell
Journal:  Mol Biochem Parasitol       Date:  1988-05       Impact factor: 1.759

9.  Evidence that the major surface proteins of three Leishmania species are structurally related.

Authors:  R J Etges; J Bouvier; R Hoffman; C Bordier
Journal:  Mol Biochem Parasitol       Date:  1985-02       Impact factor: 1.759

10.  Molecular cloning of the major surface antigen of leishmania.

Authors:  L L Button; W R McMaster
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  11 in total

1.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.

Authors:  R Garg; S K Gupta; P Tripathi; S Naik; S Sundar; A Dube
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.

Authors:  E Handman
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Evidence for rosettes as an unrecognized stage in the life cycle of Leishmania parasites.

Authors:  David M Iovannisci; C Paul Plested; Gregory R Moe
Journal:  J Eukaryot Microbiol       Date:  2010-08-05       Impact factor: 3.346

5.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Use of glycoconjugates for trypanosomatid taxonomy.

Authors:  M H Branquinha; M N Meirelles; A Lopes; C Moreira; A B Vermelho
Journal:  Curr Microbiol       Date:  1995-02       Impact factor: 2.188

8.  Two isoforms of murine hck, generated by utilization of alternative translational initiation codons, exhibit different patterns of subcellular localization.

Authors:  P Lock; S Ralph; E Stanley; I Boulet; R Ramsay; A R Dunn
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation.

Authors:  J Mehrotra; D Bisht; V D Tiwari; S Sinha
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.

Authors:  J E Haberer; A M Da-Cruz; L Soong; M P Oliveira-Neto; L Rivas; D McMahon-Pratt; S G Coutinho
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.